Company profile
IHG Pharmaco Limited
IHG Pharmaco Limited is a UK company with status active founded in 2005.
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Novel Biomarker Test with Treatment, to Predict and Prevent Miscarriage and Adverse Birth Outcomes in Ethnically Diverse Patient Populations.
1 Apr 2022 to 31 Mar 2025
The project builds on earlier Innovate funded feasibility work and comprises manufacturing a prototype test for validation and stability testing, for an eventual manufactured form of a novel test for adverse pregnancy outcomes affecting mothers and children. This will include Black and Asian ethnicity patients who are at higher risk of these adverse outco...
Developing mouthswab patient friendly testing combined with determining African/Asian incidence of a biomarker to reduce risks of adverse birth outcomes using a novel pharmacogenomic test
1 Nov 2020 to 30 Nov 2021
COVID19 has required face to face contact with patients to be as limited as possible thus making obtaining clinical trial samples very difficult. The project comprises using mouthswabs to gain access to patients DNA to genotype for the incidence of a biomarker associated with adverse birth outcomes and include the results in a large clinical study. These ...
Feasibility of Manufacturing a Reproductive Biomarker Test and Scoping for NHS Adoption in Primary Care
1 Aug 2019 to 31 Oct 2020
The project comprises determining the feasibility of making a manufactured form of a diagnostic test that can utilise capillary electrophoresis to detect an important gene associated with human health.
capillary electrophoresis
1 Aug 2015 to 31 Jan 2016
"To develop the test, supplier to prototype the assay to run on the ABI analyser as follows: The assay probes to be fluorescently labelled to produce clearer and ‘cleaner’ images to maximise assay resolution.Optimise polymer for non-denaturing run conditions Extract DNA from saliva and quantify Run assay and DNA from saliva on a long capillary using capil...